Pfm Health Sciences, LP Madrigal Pharmaceuticals, Inc. Transaction History

Pfm Health Sciences, LP

  • $1.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$171.37 - $283.23 $5.14 Million - $8.49 Million
29,973 New
29,973 $8 Million
Q2 2021

Aug 16, 2021
SELL
$97.2 - $137.59 $8.02 Million - $11.4 Million
-82,534 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$108.54 - $125.2 $8.96 Million - $10.3 Million
82,534 New
82,534 $9.65 Million

Others Institutions Holding MDGL

# of Institutions
296
Shares Held
21.9M
Call Options Held
819K
Put Options Held
644K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.52B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email